Metabolic & Endocrine
Vitamin D Deficiency
17
Pipeline Programs↗
4
Active Trials↗
13
Companies Involved↗
Vitamin D Deficiency is an emerging landscape with 17 programs across 13 companies. The most active players are Eli Lilly, Novartis, AbbVie. 3 therapies are approved with 4 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 26
Phase 34
Analysis
Trial Status
42
clinical trials
Completed26 · 62%
Unknown status6 · 14%
Terminated5 · 12%
Recruiting2 · 5%
Withdrawn1 · 2%
Not yet recruiting1 · 2%
Other1 · 2%
Clinical Trials
Trial Activity
42 trials
Effect of Vitamin D3 Supplementation on Symptomatic Uterine Fibroid in Women With Vitamin D Deficiency
Recruiting·—·Phase 1·NCT07012161·39 enrolled
Rapid Normalization of Vitamin D Deficiency in PICU
Completed·—·Phase 3·NCT03742505·424 enrolled
Does Supplementing Vitamin D Deficiency Affect Fusion Healing Rates in Elective Foot and Ankle Surgery?
Completed·—·Phase 1·NCT04450199·25 enrolled
VITdAL@ICU - Correction of Vitamin D Deficiency in Critically Ill Patients
Completed·—·Phase 3·NCT01130181·480 enrolled
Controlled Trial of Prenatal Vitamin D3 Supplementation to Prevent Vitamin D Deficiency in Mothers and Their Infants
Completed·—·Phase 3·NCT00610688·192 enrolled
Determination of Effective Vitamin D Replacement and Monitoring Strategies in Vitamin D Deficiency State
Completed·—·N/A·NCT01430793·99 enrolled
Is Treatment of Vitamin D Deficiency Associated With Resolution of Statin-Induced Muscular Symptoms
Completed·—·Phase 4·NCT01568255·11 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)